Olanzapine/fluoxetine
Template:Short description Template:Drugbox
Olanzapine/fluoxetine (trade name Symbyax, created by Eli Lilly and Company) is a fixed-dose combination medication containing olanzapine (Zyprexa), an atypical antipsychotic, and fluoxetine (Prozac), a selective serotonin reuptake inhibitor (SSRI). Olanzapine/fluoxetine is primarily used to treat the depressive episodes of bipolar I disorder[1] as well as treatment-resistant depression.[2][3]
Medical uses
Olanzapine/fluoxetine was approved by the U.S. Food and Drug Administration (FDA) to treat the depressive episodes of bipolar I disorder in 2003.[2] In 2009, it was granted approval for the treatment of treatment-resistant depression.[4]
Olanzapine/fluoxetine, or other antidepressant/antipsychotic combinations, are sometimes prescribed off-label for anxiety disorders,[5] eating disorders,[6] obsessive–compulsive disorder (OCD),[7] and posttraumatic stress disorder (PTSD).[8]
Side effects
Possible side effects of olanzapine/fluoxetine include all those of the two component drugs: olanzapine (side effects) and fluoxetine (side effects). Common side effects include suicidal thoughts, increased appetite, weight gain, drowsiness, fatigue, dry mouth, swelling, tremor, blurred vision, and difficulty concentrating.[2]
Olanzapine/fluoxetine could produce a severe allergic reaction and should not be used if the patient has previously experienced an allergic reaction to either fluoxetine or olanzapine.[9]
Olanzapine is correlated with an increase in blood sugar. Patients with diabetes, or those at risk for developing it, require careful monitoring.[9]
In rare cases, olanzapine/fluoxetine may cause neuroleptic malignant syndrome.[2]
Like other SSRIs, olanzapine/fluoxetine carries a boxed warning stating that it could increase the risk of suicidal thoughts and behaviors in patients aged 24 and under. The warning also states that olanzapine/fluoxetine may increase the risk of death in elderly patients with dementia-related psychosis.[2]
See also
- Amitriptyline/perphenazine
- Aripiprazole/sertraline
- "California rocket fuel"
- Flupentixol/melitracen
- Tranylcypromine/trifluoperazine
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "citation/CS1".
- ↑ a b c d e Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b Script error: No such module "citation/CS1".
Script error: No such module "Check for unknown parameters".
External links
- Script error: No such module "citation/CS1".
Template:Mood stabilizers Script error: No such module "Navbox". Script error: No such module "navbox". Script error: No such module "navboxes". Template:Adrenergic receptor modulators Template:Dopamine receptor modulators Template:Histamine receptor modulators Template:Monoamine reuptake inhibitors Template:Muscarinic acetylcholine receptor modulators Template:Serotonin receptor modulatorsScript error: No such module "navboxes".Script error: No such module "Check for unknown parameters". Template:OCD pharmacotherapies Template:Portal bar